University–Industry Linkages in the Support of Biotechnology Discoveries

Literature Cited

1. Aghion P, Tirole J. 1994. The management of innovation. Q. J. Econ. 109:1185–209 [Google Scholar]
2. Aharonson B, Baum J, Feldman M. 2007. Desperately seeking spillovers? Increasing returns, industrial organization and the location of new entrants in geographic and technological space. Ind. Corp. Change 16:89–130 [Google Scholar]
3. Argyres N, Liebeskind J. 1998. Privatizing the intellectual commons: universities and the commercialization of biotechnology. . J. Econ. Behav. Organ. 35:4427–54 [Google Scholar]
4. Arora A, Gambardella A. 1990. Complementarity and external linkages: the strategies of the large firms in biotechnology. J. Ind. Econ. 38:361–79 [Google Scholar]
5. Arora A, Gambardella A. 1994. Evaluating technological information and utilizing it: scientific knowledge, technological capability, and external linkages in biotechnology. J. Econ. Behav. Organ. 24:91–114 [Google Scholar]
6. Arrow K. 1962. Economic welfare and the allocation of resources for inventions. The Rate and Direction of Inventive Activity R Nelson 165–80 Princeton, NJ: Princeton Univ. Press [Google Scholar]
7. Audretsch DB, Stephan PE. 1999. Knowledge spillovers in biotechnology: sources and incentives. J. Evol. Econ. 9:97–107 [Google Scholar]
8. Banal-Estañol A, Macho-Stadler I, Pérez-Castrillo D. 2013. Endogeneous matching in university-industry collaboration: theory and empirical evidence from the UK Work. Pap., Dep. Econ. Bus., Univ Pompeu Fabra, Barcelona, Spain:
9. Barham B, Foltz J, Kim K. 2002. Trends in university ag-biotech patent production. Rev. Agric. Econ. 24:294–308 [Google Scholar]
10. Barrows G, Sexton S, Zilberman D. 2014. Agricultural biotechnology: the promise and prospects of genetically modified crops. J. Econ. Perspect. 28:99–120 [Google Scholar]
11. Beath J, Owen R, Poyago-Theotoky J, Ulph D. 2003. Optimal incentives for income-generation in universities: the rule of thumb for the Compton tax. Int. J. Ind. Organ. 21:1301–22 [Google Scholar]
12. Beaudry C, Kananian R. 2013. Follow the (industry) money: the impact of science networks and industry-to-university contracts on academic patenting in nanotechnology and biotechnology. Ind. Innov. 20:241–60 [Google Scholar]
13. Beggs AW. 1992. The licensing of patents under asymmetric information. Int. J. Ind. Organ. 10:171–91 [Google Scholar]
14. Blume-Kohout M, Kumar K, Lau C, Sood N. 2015. The effect of federal research funding on formation of university-firm biopharmaceutical alliances. J. Technol. Transf. 40:5859–76 [Google Scholar]
15. Chukumba CO, Jensen RA. 2005. University invention, entrepreneurship, and start-ups NBER Work. Pap . 11475
16. Cohen S, Chang A, Boyer H, Helling R. 1973. Construction of biologically functional bacterial plasmids in vitro. PNAS 70:3240–44 [Google Scholar]
17. Cohen WM, Levinthal DA. 1990. Absorptive capacity: a new perspective on learning and innovation. Admin. Sci. Q. 35:128–52 [Google Scholar]
18. D'Amore R, Iorio R, Labory S, Stawinoga A. 2013. Research collaboration networks in biotechnology: exploring the trade-off between institutional and geographic distances. Ind. Innov. 20:261–76 [Google Scholar]
19. Dechenaux E, Thursby M, Thursby J. 2009. Shirking, sharing risk and shelving: the role of university license contracts. Int. J. Ind. Organ. 27:80–91 [Google Scholar]
20. Diez MCF, Gil-Delgado MRC. 2003. Regulatory factors affecting the agri-food biotechnology sector in the European Union. Work. Pap. 28597, Dep. Agric. Resour. Econ Univ. Md., College Park, MD:
21. Feldman MP, Colaianni A, Liu CK. 2007. Lessons from the commercialization of the Cohen-Boyer patents: the Stanford University licensing program. ipHandbook Best Practices Blog chapter 17.22 . http://www.iphandbook.org/handbook/ch17/p22/
22. Foltz J, Barham B, Kim K. 2002. Universities and agricultural biotechnology patent production. Agribusiness 16:82–95 [Google Scholar]
23. Foltz J, Kim K, Barham B. 2003. A dynamic analysis of university agricultural biotechnology patent production. Am. J. Agric. Econ. 85:187–97 [Google Scholar]
24. Gallini NT, Wright BD. 1990. Technology transfer under asymmetric information. Rand J. Econ. 21:147–60 [Google Scholar]
25. Gittelman M. 2005. What makes research socially useful? Complementarities between in-house research and firm-university collaboration in biotechnology. Rev. Econ. Ind. 2:57–73 [Google Scholar]
26. Glenna L, Welsh R, Ervin D, Lacy W, Biscotti D. 2011. Commercial science, scientists' values, and university biotechnology research agendas. Res. Policy 40:957–68 [Google Scholar]
27. Graff G, Rausser G, Small A. 2003. Agricultural biotechnology's complementary intellectual assets. Rev. Econ. Stat. 85:349–63 [Google Scholar]
28. Guerzoni M, Taylor A, Audretsch D, Desai S. 2014. A new industry creation and originality: insight from the funding sources of university patents. Res. Policy 43:1697–706 [Google Scholar]
29. Heisey P, King J, Day Rubenstein K. 2005. Patterns of public-sector and private-sector patenting in agricultural biotechnology. AgBioForum 8:73–82 [Google Scholar]
30. Hellmann T. 2007. The role of patents for bridging the science to market gap. J. Econ. Behav. Organ. 63:624–47 [Google Scholar]
31. Hoppe HC, Ozdenoren E. 2005. Intermediation in innovation. Int. J. Ind. Organ. 23:483–503 [Google Scholar]
32. Jensen R, Thursby M. 2001. Proofs and prototypes for sale: the licensing of university inventions. Am. Econ. Rev. 91:240–59 [Google Scholar]
33. Jensen RA. 2011. Startup firms from research in U.S. universities. Handbook of Research on Innovation and Entrepreneurship DB Audretsch, O Falck, S Heblich, A Lederer 273–89 Cheltenham, UK: Edward Elgar [Google Scholar]
34. Jensen RA, Thursby JG, Thursby MC. 2003. Disclosure and licensing of university inventions: ‘the best we can do with the s**t we get to work with. Int. J. Ind. Organ. 21:1271–300 [Google Scholar]
35. Jensen RA, Thursby JG, Thursby MC. 2010. University-industry spillovers, government funding, and industrial consulting NBER Work. Pap.15732 [Google Scholar]
36. Jong S. 2008. Academic organizations and new industrial fields: Berkeley and Stanford after the rise of biotechnology. Res. Policy 37:1267–82 [Google Scholar]
37. Kato M, Odagiri H. 2012. Development of university life-science programs and university–industry joint research in Japan. Res. Policy 41:939–52 [Google Scholar]
38. Kolympiris C, Kalaitzandonakes N, Miller D. 2014. Public funds and local biotechnology firm creation. Res. Policy 43:121–37 [Google Scholar]
39. Lehrer M. 2007. Organizing knowledge spillovers when basic and applied research are interdependent: German biotechnology policy in historical perspective. J. Technol. Transf. 32:277–96 [Google Scholar]
40. Lehrer M, Asakawa K. 2004. Rethinking the public sector: idiosyncrasies of biotechnology commercialization as motors of national R&D reform in Germany and Japan. Res. Policy 33:921–38 [Google Scholar]
41. Lemarie S, Mangematin V, Torre A. 2001. Is the creation and development of biotech SMEs localised? Conclusions drawn from the French case. Small Bus. Econ. 17:61–76 [Google Scholar]
42. Liebeskind J, Oliver A, Zucker L, Brewer M. 1995. Social networks, learning, and flexibility: sourcing scientific knowledge in new biotechnology firms NBER Work. Pap 5320
43. Lim T-A, Veugelers R. 2003. On equity as a payment device in technology licensing with moral hazard Work. Pap., Dep. Manag. Econ. Strategy Innov., Kathol. Univ Leuven, Leuven, Belg.:
44. Link A, Scott J. 2005. Opening the ivory tower's door: an analysis of the determinants of the formation of U.S. university spin-off companies. Res. Policy 34:1106–12 [Google Scholar]
45. Lynskey M. 2006. Transformative technology and institutional transformation: coevolution of biotechnology venture firms and the institutional framework in Japan. Res. Policy 35:1389–422 [Google Scholar]
46. Macho-Stadler I, Martínez-Giralt X, Pérez-Castrillo D. 1996. The role of information in licensing contract design. Res. Policy 25:43–57 [Google Scholar]
47. Macho-Stadler I, Pérez-Castrillo D. 2010. Incentives in university technology transfers. Int. J. Ind. Organ. 28:362–67 [Google Scholar]
48. Macho-Stadler I, Pérez-Castrillo D, Veugelers R. 2007. Licensing of university inventions: the role of a technology transfer office. Int. J. Ind. Organ. 25:483–510 [Google Scholar]
49. Marco A, Rausser G. 2008. The role of patent rights in mergers: consolidation in plant biotechnology. Am. J. Agric. Econ. 90:133–51 [Google Scholar]
50. Marco A, Rausser G. 2011. Complementarities and spillovers in mergers: an empirical investigation using patent data. Econ. Innov. New Technol. 20:207–31 [Google Scholar]
51. McKelvey M, Alm H, Riccaboni M. 2003. Does co-location matter for formal knowledge collaboration in the Swedish biotechnology–pharmaceutical sector?. Res. Policy 32:483–501 [Google Scholar]
52. McMillan GS, Narin F, Deeds D. 2000. An analysis of the critical role of public science in innovation: the case of biotechnology. Res. Policy 29:1–8 [Google Scholar]
53. Mendel G. 1866. Versuche über Pflanzen-Hybriden [Experiments on plant hybridization]. Verh. Naturforsch. Ver. Brünn. 4:3–47 [Google Scholar]
54. Niosi J. 2006. Success factors in Canadian academic spin-offs. J. Technol. Transf. 31:451–57 [Google Scholar]
55. Oehmke J. 2001. Biotechnology R&D races, industry structure, and public and private sector research orientation. AgBioForum 4:105–14 [Google Scholar]
56. Oliver AL. 2004. Biotechnology entrepreneurial scientists and their collaborations. Res. Policy 33:583–97 [Google Scholar]
57. Owen-Smith J, Powell WW. 2003. The expanding role of university patenting in the life sciences: assessing the importance of experience and connectivity. Res. Policy 32:1695–711 [Google Scholar]
58. Owen-Smith J, Powell WW. 2006. Accounting for emergence and novelty in Boston and Bay Area biotechnology. Cluster Genesis: The Emergence of Technology Clusters and Their Implications for Government Policies P Braunerhjelm, M Feldman 61–86 Oxford, UK: Oxford Univ. Press [Google Scholar]
59. Powell WW, Brantley P. 1992. Competitive cooperation in biotechnology: learning through networks. Networks and Organizations: Structure, Form and Action N Nohria, R Eccles 366–94 Boston, MA: Harvard Bus. Sch. Press [Google Scholar]
60. Rausser GC, Scotchmer S, Simon LK. 1999. Intellectual property and market structure in agriculture Work. Pap. 880, Dep. Agric. Resour. Econ., Univ. Calif Berkeley, CA:
61. Rausser G, Simon L, Ameden H. 2000. Public-private alliances in biotechnology: Can they narrow the knowledge gaps between rich and poor?. Food Policy 25:499–513 [Google Scholar]
62. Rausser G, Small A. 1996. The economic value of patents, licenses, and plant variety protection Work. Pap. 797, Dep. Agric. Resour. Econ., Univ. Calif Berkeley, CA:
63. Schienstock G, Tulkki P. 2001. The fourth pillar? An assessment of the situation of the Finnish biotechnology. Small Bus. Econ. 17:105–22 [Google Scholar]
64. Scotchmer S. 2013. Patents in the university: priming the pump and crowding out. J. Ind. Econ. 61:817–44 [Google Scholar]
65. Shane S. 2002. Selling university technology. Manag. Sci. 48:122–37 [Google Scholar]
66. Showalter D, Jensen R. 2009. University inventions licensed through start-ups Work. Pap., Dep. Econ., Univ. Notre Dame Notre Dame, IN:
67. Silveira R, Wright R. 2010. Search and the market for ideas. J. Econ. Theory 45:1550–73 [Google Scholar]
68. Smith HL, Bagchi-Sen S. 2006. University–industry interactions: the case of the UK biotech industry. Ind. Innov. 13:371–92 [Google Scholar]
69. Stevens A. 2004. The enactment of Bayh–Dole. J. Technol. Transf. 29:93–99 [Google Scholar]
70. Stuart T, Ozdemir S, Ding W. 2007. Vertical alliance networks: the case of university–biotechnology–pharmaceutical alliance chains. Res. Policy 36:477–98 [Google Scholar]
71. Subramanian A, Lim K, Soh P. 2013. When birds of a feather don't flock together: different scientists and the roles they play in biotech R&D alliances. Res. Policy 42:595–612 [Google Scholar]
72. Thomson J. 2004. The status of plant biotechnology in Africa. AgBioForum 7:9–12 [Google Scholar]
73. Thursby JG, Jensen R, Thursby MC. 2001. Objectives, characteristics and outcomes of university licensing: a survey of major U.S. universities. J. Technol. Transf. 26:59–72 [Google Scholar]
74. Thursby J, Thursby M. 2011. University-industry linkages in nanotechnology and biotechnology: evidence on collaborative patterns for new methods of inventing. J. Technol. Transf. 36:605–23 [Google Scholar]
75. Trippl M, Todtling F. 2008. From the ivory tower to the marketplace: knowledge organizations in the development of biotechnology clusters. J. Reg. Anal. Policy 38:159–75 [Google Scholar]
76. Xia Y, Buccola S. 2005. University life science programs and agricultural biotechnology. Am. J. Agric. Econ. 87:229–43 [Google Scholar]
77. Yague-Perales R, Niosi J, March-Chorda I. 2015. Benchmarking biotechnology industries: a comparative perspective. Int. Entrep. Manag. J. 11:19–38 [Google Scholar]
78. Zhang J. 2009. The performance of university spin-offs: an exploratory analysis using venture capital data. J. Technol. Transf. 34:255–85 [Google Scholar]
79. Zucker LG, Darby MR. 1996. Star scientists and institutional transformation: patterns of invention and innovation in the formation of the biotechnology industry. PNAS 93:12709–16 [Google Scholar]
80. Zucker LG, Darby MR. 2001. Capturing technological opportunity via Japan's star scientists: evidence from Japanese firms' biotech patents and products. J. Technol. Transf. 26:37–58 [Google Scholar]
81. Zucker LG, Darby MR, Armstrong JS. 1998a. Geographically localized knowledge: spillovers or markets?. Econ. Inquiry 36:65–86 [Google Scholar]
82. Zucker LG, Darby MR, Armstrong JS. 2002. Commercializing knowledge: university science, knowledge capture, and firm performance in biotechnology. Manag. Sci. 48:138–53 [Google Scholar]
83. Zucker LG, Darby MR, Brewer MB. 1998b. Intellectual human capital and the birth of U.S. biotechnology enterprises. Am. Econ. Rev. 88:290–306 [Google Scholar]